The dental anesthesia market size is estimated to be USD 1,952.4 million in 2022 and is expected to witness a CAGR of 5.91% during the forecast period 2023-2033. Increasing disposable incomes and growing oral awareness are projected to drive the market growth in near future. Furthermore, rising problem of dental carries and surge in the prevalence of cancer, periodontitis, and gingivitis are other factors projected to support the market growth. However, strict government regulations, and the use of conventional remedies are predicted to limit market growth.

Rising problem of dental carries is expected to propel the market growth during the forecast period. According to a World Health Organization (WHO) report, dental caries is the biggest concern, affecting 60 to 90% of children. Levonordefrin and epinephrine, two vasoconstrictors, are therefore widely distributed in the United States. Additionally, epinephrine-based dental anaesthetics including bupivacaine, prilocaine, articaine, and lidocaine are often used in many different countries.

Surge in the prevalence of cancer, periodontitis, and gingivitis is predicted to fuel the market growth during the projected period. A surge in the prevalence of cancer, periodontitis, and gingivitis is expected to increase demand for dental anesthesia globally. It is anticipated that dietary preferences and tobacco and cigarette use will change, increasing the risk of oral and maxillofacial dental issues.

Segmentation

By Product

The market is categorized into general, local, sedation. In 2022, the local segment accounted for the highest revenue share due to the fact that local anesthetic is used to treat simpler procedures that take less time to complete and are often easier, such filling cavities. It is the most popular option as it is generally the safest option and has the least negative consequences. Clinical dentists have used local anesthesia as the eighteenth century to lessen or completely eliminate the discomfort connected with invasive treatments. Local anesthesia is also frequently used during oral and maxillofacial surgery. Local anesthesia is most commonly used by dentists (LAs). They are more safer medicines. More than 40% of dental emergencies are uncomfortable enough that LA injections are required.

By End User

The market is categorized into dental clinics, hospitals, and others. In the global market, the dental clinics segment accounted for the largest revenue share in 2022 owing to expanding number of dental offices around the world and the widespread use of advanced dentistry by both large and small dental practices. Additionally, it is anticipated that the rise of dental clinics, particularly in developed nations, will accelerate the market’s progress. In industrialized nations, public healthcare offers dentists appropriate compensation for their procedures and services, depending on the region. There may be a chance for dental clinics to prosper due to the growing popularity of the dental franchise concept. The benefits of a dental franchise model include better negotiation position and cost reductions due to economies of scale. There may also be a chance for dental clinics to prosper due to the growing popularity of the dental franchise model. A dental franchise concept has benefits including improved negotiation leverage and cost savings through economies of scale.

Regional Markets

In 2022, Asia Pacific region accounted for the highest revenue in the dental anesthesia market and is expected to maintain its dominance during the forecast period. This is attributed to rising incidence of dental issues in both children and adults, favourable government initiatives, a sizable population, and the presence of advanced medical facilities and increase in oral health awareness. Dentists are increasingly recommending dental implants to replace missing natural teeth in densely populated countries such as India and China. These countries experience a heavy burden of dental and oral conditions, which is driving greater demand for routine dental checks and visits. Additionally, China and India are currently the largest tobacco producers and consumers with the lowest levels of understanding of the risks associated with smoking.

Competitor Insights

Some of the key players operating in the dental anesthesia market are Dentalhitec, Laboratorios Inibsa, Denstply Sirona, Pierre Pharma, Aspen Group, Laboratorios Normon, Primex Pharmaceuticals, Septodont, and Zeyco.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

• For instance, Septodont introduced the Dentapen electronic syringe for dental anesthesia in November 2018. Additionally, a number of companies are working together to create cutting-edge technology in order to promote their products faster.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including type and end user from 2022 to 2033.

Report Scope:

Segmentation: Dental Anesthesia Market Report 2022 – 2033

Type (Revenue, USD Million), 2022 – 2033

• General
• Local
• Sedation

End user (Revenue, USD Million), 2022 – 2033

• Dental Clinics
• Hospitals
• Others

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA